GKOS earnings date and last-quarter result: next report 2026-07-29, last quarter beat, P/E -46.60. Updated 2026-07-23.
Glaukos (GKOS) Research Hub
Glaukos (GKOS) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 178.27 USD (-0.34%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -46.60, market cap 8.91B. This hub links to the full technical, earnings and options research available for GKOS.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 178.27 USD (-0.34%) |
| 52-week range | 126.67 USD – 190.06 USD |
| Trend regime | Range |
| 14-day RSI | 66.3 (Bullish) |
| Trailing P/E | -46.60 |
| Market cap | 8.91B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-29 |
Available research for GKOS
Covered Call on GKOS: how it works, illustrative setup around the real 178.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GKOS: how it works, illustrative setup around the real 178.27 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GKOS: how it works, illustrative setup around the real 178.27 USD price, max profit/loss, breakeven and when to use it. Educational.
GKOS technical analysis: range, last 178.27 USD, RSI 66.3, 52w range 126.67 USD–190.06 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is GKOS in?
Glaukos (GKOS) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is GKOS in an uptrend or downtrend?
As of 2026-10-26, GKOS is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GKOS's trailing P/E ratio?
GKOS's trailing P/E is -46.60, with a market cap of 8.91B. See the earnings research page for full valuation detail.
When does GKOS next report earnings?
GKOS is next scheduled to report earnings on 2026-07-29.